Abstract:Benefiting from the advantages of minimal invasiveness, painlessness, and ease to use, microneedle patches (MPs) have been extensively studied in the biomedical field through a physical penetration enhancement pathway. This study systematically summarizes the preparation methods, function optimization, and diagnostic and therapeutic applications of MPs. First of all, the raw materials and methods commonly used in different preparation processes for MPs are highlighted. Then, the corresponding solutions to the … Show more
“…The tunable nature of the microneedles (i.e., materials from which they are produced, microneedle morphology, etc.) offer opportunities to control the release kinetics, and the integration of such microneedle arrays within devices capable of sensing analytes [ 75 , 76 , 77 , 78 ] that are biomarkers of medical conditions and triggering the delivery of the drug from the microneedle arrays, [ 18 , 30 , 71 , 79 , 80 , 81 ] offers long term potential for controlling the delivery of the drug in line with the chronobiology of the condition being treated that offers significant potential savings to healthcare systems worldwide. Such microneedles are one of a host of potential methods of non‐invasive delivery technologies [ 82 , 83 ] being developed by multidisciplinary research and development teams of people based in academic, industrial, and clinical settings will be involved to translate unique technical know‐how to the benefit of humanity, [ 6 ] and the interest in the application of microneedles for biomedical applications is demonstrated both by the volume of academic literature produced, [ 12 , 84 ] and moreover the fact that there are currently >500 entries including the term microneedles in their title, abstract or keyword in the Cochrane Central Register of Controlled Trials.…”
The release of metformin, a drug used in the treatment of cancer and diabetes, from poly(2‐hydroxyethyl methacrylate), pHEMA, hydrogel‐based microneedle patches is demonstrated in vitro. Tuning the composition of the pHEMA hydrogels enables preparation of robust microneedle patches with mechanical properties such that they would penetrate skin (insertion force of a single microneedle to be ≈40 N). Swelling experiments conducted at 20, 35, and 60 °C show temperature‐dependent degrees of swelling and diffusion kinetics. Drug release from the pHEMA hydrogel‐based microneedles is fitted to various models (e.g., zero order, first order, second order). Such pHEMA microneedles have potential application for transdermal delivery of metformin for the treatment of aging, cancer, diabetes, etc.
“…The tunable nature of the microneedles (i.e., materials from which they are produced, microneedle morphology, etc.) offer opportunities to control the release kinetics, and the integration of such microneedle arrays within devices capable of sensing analytes [ 75 , 76 , 77 , 78 ] that are biomarkers of medical conditions and triggering the delivery of the drug from the microneedle arrays, [ 18 , 30 , 71 , 79 , 80 , 81 ] offers long term potential for controlling the delivery of the drug in line with the chronobiology of the condition being treated that offers significant potential savings to healthcare systems worldwide. Such microneedles are one of a host of potential methods of non‐invasive delivery technologies [ 82 , 83 ] being developed by multidisciplinary research and development teams of people based in academic, industrial, and clinical settings will be involved to translate unique technical know‐how to the benefit of humanity, [ 6 ] and the interest in the application of microneedles for biomedical applications is demonstrated both by the volume of academic literature produced, [ 12 , 84 ] and moreover the fact that there are currently >500 entries including the term microneedles in their title, abstract or keyword in the Cochrane Central Register of Controlled Trials.…”
The release of metformin, a drug used in the treatment of cancer and diabetes, from poly(2‐hydroxyethyl methacrylate), pHEMA, hydrogel‐based microneedle patches is demonstrated in vitro. Tuning the composition of the pHEMA hydrogels enables preparation of robust microneedle patches with mechanical properties such that they would penetrate skin (insertion force of a single microneedle to be ≈40 N). Swelling experiments conducted at 20, 35, and 60 °C show temperature‐dependent degrees of swelling and diffusion kinetics. Drug release from the pHEMA hydrogel‐based microneedles is fitted to various models (e.g., zero order, first order, second order). Such pHEMA microneedles have potential application for transdermal delivery of metformin for the treatment of aging, cancer, diabetes, etc.
“…[123][124][125] The biomedical applications of microneedles on wound healing and monitoring are also extensively discussed. [126][127] The tremendous potential of microneedle-based devices with therapeutic functions would be able to answer many desires arising for allin-one theranostic systems, which can bridge the gap between wearable sensing bioelectronics and the next-generation healthcare platforms. Therefore, recent advances in therapeutic microneedles are highlighted in the section.…”
The rapid development of wearable biosensing calls for next‐generation devices that allow continuous, real‐time, and painless monitoring of health status along with responsive medical treatment. Microneedles have exhibited great potential for the direct access of dermal interstitial fluid (ISF) in a minimally invasive manner. Recent studies of microneedle‐based devices have evolved from conventional off‐line detection to multiplexed, wireless, and integrated sensing. In this review, the classification and fabrication techniques of microneedles are first introduced, and then the representative examples of microneedles for transdermal monitoring with different sensing modalities are summarized. State‐of‐the‐art advances in therapeutic and closed‐loop systems are presented to formulate guidelines for the development of next‐generation microneedle‐based healthcare platforms. The potential challenges and prospects are discussed to pave a new avenue toward pragmatic applications in the real world.
“…The pH value and inflammatory factors of wound secretions are closely related to wound healing, [ 85 ] and real‐time effective monitoring of these indicators is bound to better tailor specific targeted treatment plans according to disease changes. [ 86 ] If it can integrate the functions of promoting wound healing and monitoring the status of the wound, it will greatly facilitate the timely healing of skin wounds. Due to its excellent biocompatibility, injectable, and good self‐healing ability, hydrogels have gradually become the leader in dressing in recent years.…”
Section: Microneedles To Diagnose and Monitor Healthmentioning
Wound healing, especially chronic wounds, has been one of the major challenges in the field of biomedicine. Drug therapy alone is not effective, so a variety of functional wound healing dressings have been developed. Microneedles have attracted more and more attentions in the field of wound healing dressings due to their penetration and high drug delivery efficiency. In this review, all the studies on the application of microneedles in wound healing in recent years are summarized, classify different microneedles according to their functions in the process of wound healing, discuss the current challenges in the transformation of microneedle technology toward clinical applications, and finally look forward to the future design and development directions of microneedles in this field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.